News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex

ReShape Lifesciences Inc

ReShape Lifesciences CEO Paul Hickey joined Steve Darling from Proactive to share significant news regarding the approval of the company's next-generation Lap-Band® 2.0 FLEX by the U.S. Food and Drug Administration. Hickey told Proactive this FDA approval represents a historic event for ReShape Lifesciences and is expected to serve as a pivotal driver of growth for the company's Lap-Band franchise. The development of the enhanced Lap-Band 2.0 FLEX was led by physicians with a primary focus on improving the overall patient experience. This FDA approval marks a significant milestone for ReShape Lifesciences, highlighting the company's commitment to advancing patient-centered innovations in the field of medical devices. Contact Details Proactive USA +1 347-449-0879 na-editorial@proactiveinvestors.com

December 21, 2023 07:00 AM Eastern Standard Time

Video
Article thumbnail News Release

Polarean Imaging "very excited" to announce brand new customer for XENOVIEW polariser

Polarean Imaging PLC

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) CEO Christopher von Jako speaks to Thomas Warner from Proactive after the medical imaging technology company announced its first de novo order for its XENOVIEW polariser. Von Jako explains that the latest order, from a renowned medical institution in the Northeast, represents a significant step as it is from a brand new customer. Von Jako, who took the helm in July, also highlights the company's work with Dutch multinational Philips, emphasising the seamless integration of their products, including FDA-approved MRI coils. This collaboration extends to training Philips' commercial staff in the U.S., promising further growth in 2024. Additionally, Polarean is pursuing strategic growth initiatives, including increasing utilisation of their technology at sites like Cincinnati Children's Hospital and the University of Missouri. The company is also focusing on expanding its footprint and establishing Medicare reimbursement, thus enhancing its financial viability. Another key initiative involves conducting a clinical trial for FDA approval to explore new lung functions, potentially revolutionising lung imaging technology. In terms of financials, von Jako expressed confidence in closing the funding gap by the third quarter of the next year, supported by strategic investors. Contact Details Proactive UK Ltd Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

December 21, 2023 06:55 AM Eastern Standard Time

Video
Article thumbnail News Release

Nooro Knee Massager Reviews: Is It Worth Buying?

Renske Technologies

Have you ever found yourself grappling with persistent knee discomfort and wondered about the underlying reasons? Often, the culprit is the gradual erosion of the crucial cushioning within your knee joints, known as cartilage. This gradual wear and tear set the stage for a distressing phenomenon – bone-on-bone knee pain. This not only manifests as acute discomfort but also introduces unwelcome companions in the form of swelling and an unsettling, shaky sensation in your knees. The ramifications of this condition extend far beyond mere physical discomfort. Simple, everyday activities that were once taken for granted – like driving, climbing stairs, and even achieving a restful night's sleep – suddenly become surprisingly challenging. The pain becomes more than just a physical sensation; it transforms into a formidable barrier that robs you of the freedom to engage in activities that were once second nature. However, amidst these challenges, there is a beacon of hope – the Nooro Knee Massager. This innovative device emerges as a promising solution to break free from the clutches of chronic knee pain. By combining advanced technology with a thoughtful design, Nooro Knee Massager offers the potential to reverse the impact of cartilage wear and tear. It becomes not just a device but a pathway to reclaiming comfort and regaining the freedom to partake in activities that were once hindered by persistent knee pain. Imagine a life where driving, ascending stairs, and even enjoying a peaceful night's sleep are no longer fraught with discomfort. The Nooro Knee Massager holds the promise of transforming this vision into reality. It's not merely a product; it's a catalyst for change, offering a renewed sense of well-being and the prospect of a life unburdened by the constraints of chronic knee pain. Kindly embrace the hope that the Nooro Knee Massager brings – a hope for a future where your knees no longer dictate the limitations of your daily life. Does it really work as advertised? What Is Nooro Knee Massager? Introducing the Nooro Knee Massager – a revolutionary device designed to provide targeted relief and relaxation for your knees. Engineered with advanced technology and ergonomic design, this innovative knee massager aims to redefine the way we address knee discomfort and promote overall joint well-being. The Nooro Knee Massager is equipped with customizable massage modes, allowing users to tailor their experience based on individual preferences and specific therapeutic needs. Its sleek and compact design ensures portability, enabling users to enjoy soothing knee massages anytime, anywhere – whether at home, in the office, or on the go. Crafted with a focus on user comfort, the Nooro Knee Massager features adjustable straps to accommodate various knee sizes and ensure a snug fit during use. The device incorporates a combination of heat therapy and massage, providing a dual-action approach to alleviate tension, reduce stiffness, and enhance blood circulation around the knee joint. Powered by cutting-edge technology, the Nooro Knee Massager is user-friendly, with intuitive controls that make it easy to navigate through different settings. Its rechargeable battery ensures long-lasting use, making it a convenient and sustainable solution for those seeking regular knee relief. Whether you are an athlete recovering from intense workouts, an individual managing chronic knee issues, or someone simply looking to pamper and relax your knees after a long day, the Nooro Knee Massager stands out as a versatile and effective solution. Nooro Knee Massager Consumer Appeal: The Combination of Three Effective Therapies Made through a collaboration with the US-based startup Nooro and spearheaded by the expertise of Dr. Jeremy, a distinguished bone specialist, the Nooro Knee Massager represents a groundbreaking advancement in knee care. This innovative device integrates three highly effective therapeutic approaches to address and alleviate persistent knee discomfort. Firstly, the inclusion of Red Light Therapy sets the Nooro Knee Massager apart. This therapy stimulates the natural production of collagen, a vital component in the regeneration of cartilage. By harnessing the power of red light, this massager aims to reverse cartilage damage, providing a proactive solution to a common source of knee pain. Complementing this, the Heat Therapy feature plays a pivotal role in promoting holistic healing. As the massager applies gentle heat, it effectively loosens muscles both around and within the knee joint. This not only enhances flexibility but also encourages improved blood circulation, fostering a conducive environment for faster healing. Heat therapy is a well-established method for addressing muscle and joint discomfort, and its integration into the Nooro Knee Massager adds a valuable dimension to its therapeutic capabilities. The third key element is Massage Therapy, an essential component in the quest for knee relief. By employing targeted massage techniques, this massager effectively relaxes tight muscles and tissues surrounding the knee. Beyond mere physical relaxation, this aspect of the therapy replaces the sensation of knee pain with a profound sense of relief, making the Nooro Knee Massager a comprehensive solution for individuals grappling with chronic knee discomfort. The overarching goal of the Nooro Knee Massager is to not merely provide symptomatic relief but to actively contribute to the restoration of cartilage, reduction of inflammation, and almost instantaneous pain relief. Its user-friendly design enhances its practicality, allowing users to effortlessly apply the massager by sliding it onto the affected knee, pushing the "on" button, and indulging in a targeted 15-minute therapy session. MUST SEE: Click Here Now To Get The Nooro Knee Massager Directly From The Official Website Features and Benefits (Nooro Knee Massager Reviews) Triple-Therapy Precision: Red Light Therapy: Stimulates collagen production, actively reversing cartilage damage. Heat Therapy: Loosens muscles and promotes blood flow for accelerated healing. Massage Therapy: Targeted relaxation of tight muscles, providing immediate relief. Collaborative Innovation: Developed in collaboration with Nooro, a US-based startup, and guided by Dr. Jeremy, a renowned bone specialist. Cartilage Restoration: Aims to restore and rejuvenate cartilage, addressing a fundamental source of knee pain. Non-Invasive Alternative: Offers a surgery-free solution, reducing the need for invasive interventions. User-Friendly Design: Easy application – simply slide onto the knee, push the "on" button, and enjoy a 15-minute targeted therapy session. Portable Convenience: Compact and portable, enabling use at home, in the office, or on the go. Fast Pain Relief: Provides almost instant relief, making it an effective solution for acute discomfort. Positive User Reviews: Garnered positive feedback for its transformative impact on chronic knee discomfort. Holistic Healing: Addresses not just symptoms but actively contributes to cartilage restoration, inflammation reduction, and overall knee health. Long-Lasting Battery: Rechargeable battery ensures prolonged use, enhancing sustainability. Customizable Modes: Adjustable settings allow users to tailor the experience to their preferences and therapeutic needs. Versatile Applications: Suitable for various knee sizes, accommodating a wide range of users. Does Nooro Knee Massager Really Work And Should You Buy It? In the realm of knee pain relief, the Nooro Knee Massager emerges as a formidable tool, addressing the core causes of joint discomfort with a foundation firmly rooted in rigorous scientific principles. This three-in-one massager harnesses the power of red light treatment, thermotherapy, and vibrations to provide a holistic solution for stabbing joint pain, numbness, and stiffness. Unlike conventional solutions, the Nooro Knee Massager is not merely a palliative measure but a scientifically backed intervention. Rigorous investigations support its efficacy, making it a trustworthy choice for individuals seeking genuine relief from persistent knee joint issues. The Nooro Knee Massager's prowess lies in its triple-threat approach. Red light treatment stimulates natural healing by addressing cartilage damage. Thermotherapy eases muscles and improves blood circulation, fostering an environment conducive to healing. Simultaneously, targeted vibrations offer a therapeutic massage, relaxing tight muscles and tissues around the knee. This massager not only alleviates pain but contributes to improved mobility. Users report relief from stabbing joint pain, numbness, and stiffness, highlighting the device's efficacy in enhancing overall knee function. The Nooro Knee Massager goes beyond symptomatic relief; it actively combats inflammation and swelling, providing a comprehensive solution to weariness associated with knee discomfort. Nooro Knee Massager Scam or Legit Consumer Reports? In the realm of knee pain relief, the Nooro Knee Massager has emerged as a beacon of hope for thousands, promising not just relief but a transformative journey towards enhanced knee health. As with any revolutionary product, skepticism often accompanies acclaim. One of the cornerstones of Nooro Knee Massager's credibility lies in its overwhelmingly positive user reviews. Numerous consumers have not only reported effective pain relief but have gone a step further, recommending the device to friends and relatives. The consensus among users is that the massager delivers on its promise of quick pain alleviation, debunking initial skepticism. Users suffering from various knee concerns, including stabbing knee pain, meniscus issues, and tendon concerns, have found solace in the Nooro Knee Massager. Its effectiveness extends beyond common knee ailments, showcasing its versatility in managing diverse pain-related challenges. The Nooro Knee Massager stands out as a cost-effective alternative to traditional solutions like surgery and therapy sessions. Its accessibility makes it an attractive choice, particularly for those seeking relief without the financial burden associated with other treatments. Backed by rigorous scientific testing spanning two years before release, the Nooro Knee Massager incorporates three targeted therapies: red light therapy, heat therapy, and massage therapy. The combination of these therapies sets it apart as a professionally proven choice for pain management, relieving joint pain and promoting overall joint health. The Nooro Knee Massager's 3-in-1 technology, encompassing high-frequency vibrations, heat therapy, and targeted design, delivers precise and effective knee massage. Designed to avoid the situation and alleviate joint pain, this innovative device has undergone thorough testing to ensure long-lasting relief with just a few applications. Is Nooro Knee Massager Safe For Use? The Nooro Knee Massager has achieved the esteemed status of being FDA-approved as a Class II medical device. This classification places it in the category of devices that are considered safe and effective for their intended use. The rigorous evaluation process conducted by the FDA adds a layer of credibility to the massager, offering users the assurance that it meets stringent standards for safety and performance. One of the key takeaways from Nooro Knee Massager's FDA approval is its safety for universal use. As a Class II medical device, it has been deemed safe for use by individuals across various demographics. This inclusivity ensures that people of all ages and backgrounds can confidently incorporate the Nooro Knee Massager into their wellness routines. The safety certification doesn't just stop at individual usage – it extends to the massager's adaptability to different environments. Whether you're at home, in the office, or on the go, the Nooro Knee Massager is designed to provide a safe and effective solution for knee pain relief. This versatility underscores its commitment to enhancing well-being without compromising safety standards. FDA approval for the Nooro Knee Massager removes potential barriers for individuals seeking a reliable and safe solution for knee discomfort. It signifies that the device has undergone thorough testing and meets the FDA's stringent criteria for safety and efficacy. Pros and Cons of Nooro Knee Massager Pros: (Nooro Knee Massager Reviews Consumer Reports and Complaints On Amazon) Effective triple therapy – Red Light, Heat, and Massage. FDA-approved as a Class II medical device. Versatile and portable design for use anywhere. Non-invasive alternative to surgeries. Affordable compared to other knee pain solutions. Suitable for various knee sizes. Wirelessly rechargeable for convenience. Cons: (Nooro Knee Reviews) May not provide the same results for everyone. Requires consistent use for optimal results. Availability may be subject to demand on the official website. May not replace the need for professional medical advice. Effectiveness may vary based on individual conditions. Price Of Nooro Knee Massager And Where To Buy The Nooro Knee Massager can be gotten directly from the official website at the following prices: 1 Nooro Knee Massager costs $179.95 2 Nooro Knee Massagers cost $169.95 each 3 Nooro Knee Massagers cost $159.95 each 4x Nooro Knee Massagers cost $149.95 each 6x Nooro Knee Massagers cost $139.95 each CLICK HERE NOW TO GET THE NOORO KNEE MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE How To Use And Care for Your Nooro Knee Massager? Using Your Nooro Knee Massager: Positioning: Place the Nooro Knee Massager on the affected knee, ensuring a snug fit with the adjustable straps. The device is designed for easy application, allowing you to focus the therapeutic effects precisely. Powering On: Press the "on" button to activate the massager. The user-friendly design ensures a straightforward operation, allowing you to initiate a 15-minute targeted therapy session with ease. Customization: Adjust the settings based on your preferences and therapeutic needs. The Nooro Knee Massager is designed for versatility, allowing you to tailor the experience to your unique requirements. Relax and Enjoy: Sit back and relax as the triple therapy – Red Light, Heat, and Massage – works to alleviate knee discomfort. Take advantage of this time to unwind and experience the soothing benefits of the Nooro Knee Massager. Taking Care of Your Nooro Knee Massager: Cleaning: Use a soft, damp cloth to clean the surface of the massager. Avoid harsh chemicals or abrasive materials to prevent damage to the device. Storage: Store the Nooro Knee Massager in a cool, dry place when not in use. Keep it away from direct sunlight and extreme temperatures. Charging: Charge the massager wirelessly using the provided charging cable. Ensure the device is fully charged before each use for optimal performance. Battery Maintenance: To prolong the battery life, avoid completely draining the battery before recharging. Charge the Nooro Knee Massager regularly, especially if it hasn't been used for an extended period. Avoid Submerging: The Nooro Knee Massager is not waterproof. Avoid submerging it in water or exposing it to excessive moisture. Handle with Care: While the Nooro Knee Massager is designed for durability, handle it with care to avoid unnecessary impact or stress on the device. Regular Checkups: Periodically check the device for any signs of wear or damage. If you notice any issues, contact the manufacturer for guidance on maintenance or potential repairs. Final Verdict On Nooro Knee Massager Reviews The final verdict on Nooro Knee Massager is a positive one, backed by its innovative design, FDA approval, and positive user reviews. The device employs a triple-therapy approach, combining Red Light, Heat, and Massage therapies to address knee discomfort effectively. In conclusion, Nooro Knee Massager appears to be a legitimate and effective solution for individuals dealing with knee discomfort. Its innovative approach, positive user reviews, and FDA approval contribute to a favorable final verdict. As with any health-related product, individuals are encouraged to consult with healthcare professionals if they have specific concerns or conditions. CLICK HERE NOW TO GET THE NOORO KNEE MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Disclaimer: This article should not be mistaken as a substitute for medical advice. Individual results may vary, consult a healthcare professional before use. Contact Details Reviewzenith Louis +44 7746 698754 Apexreviews154@gmail.com Company Website https://reviewzenith.com

December 16, 2023 08:30 AM Eastern Standard Time

Image
Article thumbnail News Release

ProSomnus CEO Len Liptak unveils game-changing device and promising clinical trial results for 2024

ProSomnus

ProSomnus Inc CEO Len Liptak joined Steve Darling from Proactive to discuss the company's groundbreaking intramural mouth guard, which has received FDA clearance as a medical device for the treatment of obstructive sleep apnea and snoring. The ProSomnus device effectively positions the jaw forward during sleep, preventing airway collapse and addressing sleep apnea issues. Liptak emphasized the significance of the FDA clearance, which allows for insurance reimbursement and categorizes the ProSomnus device as a therapeutic solution for sleep apnea and snoring. The company is strategically targeting the substantial market of individuals who discontinue the use of CPAP (Continuous Positive Airway Pressure) machines, estimated at 3 to 4 million people annually. In light of the recent Philips CPAP recall, ProSomnus is positioning itself as a leading alternative to CPAP treatment for obstructive sleep apnea. The company has a strong foundation of scientific data supporting the efficacy of its device. Financially, ProSomnus has reported record revenues and a remarkable 46% year-to-date growth, demonstrating its commitment to cost reduction and maintaining a robust bottom line. Looking ahead to 2024, ProSomnus has ambitious plans for continued growth. These initiatives include FDA filings to expand labeling for the device and the development of a next-generation device featuring an oxygen sensor for real-time patient monitoring. The company prioritizes personalized manufacturing to ensure optimal treatment effectiveness and has achieved promising results in clinical trials, with a manuscript set for release in 2024. In summary, ProSomnus is dedicated to making sleep apnea treatment more accessible and technologically advanced, offering an innovative solution to improve the lives of those affected by sleep apnea and snoring. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

December 12, 2023 02:17 PM Eastern Standard Time

Video
Article thumbnail News Release

PathPresenter Selected by Cincinnati Children’s to Provide Comprehensive Digital Pathology Workflow Solution

PathPresenter

PathPresenter, the global image sharing platform for pathology, was recently selected by Cincinnati Children’s to provide an integrated digital pathology workflow solution to meet the health system’s requirements across clinical care, remote consultations, education, and research. Cincinnati Children’s, which ranks No. 1 in the nation in U.S. News & World Report’s listing of Best Children’s Hospitals for 2023-24, recently completed an extensive selective process to procure a comprehensive digital pathology workflow solution. Cincinnati Children’s, utilizing PathPresenter’s platform, seeks to improve workflow efficiencies (enabled by tight integration with its laboratory information system); expand its digital consultation network; provide new educational capabilities to advance clinical competency testing; and enable enhanced research capabilities with the ability to connect any type of AI algorithm – from 3 rd party vendors or developed in-house. PathPresenter is a secure and scalable multi-tenant enterprise workflow platform that has been developed by pathologists with deep domain knowledge and experience. Trusted by 45+ tier-one institutions, PathPresenter is the most comprehensive suite available for clinical care, remote consultations, education, and research. With expert guidance in storage optimization, tight integration with LIS systems through a proprietary HL7 engine, and robust incorporation of 3 rd party and in-house-built AI algorithms, PathPresenter ensures genuine value to institutions – without the marketing noise. While Cincinnati Children’s doesn’t endorse or sponsor any commercial products, services, or companies, Dr. Jennifer Picarsic, MD, director of Digital Pathology and AP Informatics at Cincinnati Children’s, noted that a successful digital pathology program relies not just on scanning and viewing digital slides, but rather a re-imagined vision for how pathology will be practiced in the future. “As pathology leaders, we seek to build a new digitally integrated workflow that will enhance clinical, education and research opportunities to facilitate new innovations and wider access to our expert pathologists from anywhere in the world,” Picarsic said. Dr. Rajendra Singh, founder of PathPresenter, added “We are honored to work with the excellent clinical and technical teams at Cincinnati Children’s, given their thorough understanding and deep knowledge of what they need from a workflow provider with a complete focus on improving efficiencies ensuring better care of their precious patients. PathPresenter was created to fill in the gaps in use of digital pathology, and this further fulfills our mission.” About PathPresenter PathPresenter is the global image sharing platform for pathology. We are on a mission to help democratize access to the world’s pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer, Dr. Rajendra Singh, PathPresenter has been adopted by 45+ tier one medical institutions for clinical care, remote consultations, education, and research, and has built a thriving community of 50,000+ users in 172 countries to easily view and share digital pathology images and knowledge. For more information visit www.pathpresenter.com. Contact Details Cory Batenchuk +1 873-355-9913 cory@pathpresenter.com Company Website https://pathpresenter.com

December 11, 2023 09:00 AM Eastern Standard Time

Article thumbnail News Release

Epicenter of Healthcare Transformation: The Intelligent Health Association's 2023 International Summit starts tomorrow, Monday, December 11

1BusinessWorld

In an era where technological evolution is pivotal to healthcare advancements, the Intelligent Health Association (IHA) proudly announces the launch of its 2023 International Summit. This year's summit, occurring from December 11 to December 15, 2023, represents a paradigm shift in healthcare conferences. Embracing a fully virtual format, the summit ensures accessibility for all, enabling professionals globally to engage with leading healthcare insights without the constraints of physical attendance. https://1businessworld.com/2023-intelligent-health-summit/ Reimagining Healthcare Through Digital Transformation The Intelligent Health Association is at the forefront of orchestrating an event that mirrors the current landscape of healthcare - a blend of technological innovation and practical applications. This summit is not just an event; it's an intellectual symposium, bringing together the brightest minds to discuss, debate, and shape the future of healthcare. Key Topics and Educational Excellence Over the course of five days, the summit will delve into critical areas such as AI's impact on healthcare, cybersecurity in patient data management, advancements in telehealth, the imperatives of health equity, and the integration of innovative technologies in healthcare settings. Each day is meticulously crafted to offer a comprehensive understanding of these key areas: - Exploring the role of AI in enhancing healthcare delivery. - Navigating the complexities of data and cybersecurity in healthcare. - Evaluating the evolution of telehealth in a post-pandemic era. - Championing the cause of global health equity. - Understanding the necessity of change management in adopting new technologies. A Commitment to Continuing Medical Education In an effort to empower healthcare professionals worldwide, the IHA, in collaboration with the Weitzman Institute, is offering Continuing Medical Education (CME) credits for this summit. This initiative underscores our commitment to ongoing professional development in the healthcare sector. Leadership Insights and Global Collaboration Harry P. Pappas, Founder and CEO of the Intelligent Health Association, emphasizes the summit's role in shaping healthcare's future. "This summit represents a confluence of thought leadership and innovative practices that are essential for the evolution of healthcare. We are creating a forum where ideas meet implementation," remarks Pappas. Echoing this sentiment, Sherri Douville, CEO at Medigram and Co-Chair of the Intelligent Health Summit, highlights the summit's multidisciplinary approach. "Our objective is to forge a nexus of technology, policy, and healthcare. This summit is a testament to our dedication to driving healthcare forward through leadership and transformation," states Douville. Invitation to Join a Transformative Journey The Intelligent Health Association extends an invitation to healthcare professionals, industry experts, policymakers, and academicians to join this groundbreaking event. The fully virtual format of this summit opens doors for a global audience, making it an inclusive and easily accessible platform for sharing and learning. Together, we can chart a new course for healthcare that is more adaptive, equitable, and innovative. https://1businessworld.com/2023-intelligent-health-summit/ All news and content distribution in partnership with News Direct. About the Intelligent Health Association: The Intelligent Health Association (IHA) is a global consortium of healthcare and technology leaders committed to advancing digital healthcare. Our goal is to disseminate unbiased information on innovative technologies that enhance patient care and improve clinical and business processes. The IHA champions the transformation of healthcare through high-quality educational programs and networking events, facilitating the adoption and implementation of new technologies in health and wellness ecosystems. We are dedicated to reshaping healthcare through innovation and leadership, ensuring a future where technology seamlessly integrates with patient care. Intelligent Health Association About 1BusinessWorld: 1BusinessWorld is a global business ecosystem, network and marketplace that provides entrepreneurs, business owners and professionals with the information, tools, resources and connectivity needed to succeed throughout their company’s growth journey, toward a better business world. Our vision is based on the reality that we live, work and do business in one global interconnected business environment, and hence our motto: “One World, One Business World”. Our mission is to encourage and support global communication and collaboration among entrepreneurs, professionals, and businesses. 1BusinessWorld Contact Details Media Enquiries +1 212-220-6677 info@1businessworld.com Company Website https://1businessworld.com

December 10, 2023 02:04 PM Eastern Standard Time

Image
Article thumbnail News Release

Senzime's CEO shares breakthrough patient monitoring technology for safer surgeries

Senzime

Senzime CEO Phillip Siberg joined Steve Darling from Proactive from the OTC studio in New York City to shed light on the innovative solutions offered by Senzime, aimed at significantly enhancing patient safety during and post-surgery through the power of advanced algorithms. Senzime's impressive array of tools, such as the TetraGraph and ExSpiron 2Xi, leverage real-time monitoring of neuromuscular and respiratory functions—crucial parameters during and after surgical procedures. The overarching objective of these cutting-edge technologies is to reduce in-hospital complications dramatically and drive down healthcare costs associated with surgical and high-acuity procedures. One exciting development that Siberg shared is Senzime's success in securing multiple new orders for the TetraGraph system, particularly from several prestigious German university hospitals. The German market has proven to be a strong and fruitful one for Senzime, with the company already having secured nearly 30 major hospital contracts, including pivotal partnerships with key robotic surgery centers. This expansion and adoption of Senzime's technology underscore the growing recognition of the transformative potential of their solutions within the medical community. With a robust growth trajectory, Senzime aims to achieve $30 million in sales by 2025, with the US being a pivotal market. The company's strategic move to cross-trade on the OTCQX provides accessibility to US capital markets, facilitating increased shareholder participation. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

December 08, 2023 01:25 PM Eastern Standard Time

Video
Article thumbnail News Release

HippoFi (OTC:ORHB) Hires World’s Top Regenerative Therapy Expert Dr. Gail Naughton to Drive Commercialization Plans of its Proprietary Technologies

CGR - HippoFi Inc.

There’s a strong possibility that you have experienced lower back pain or heard of injuries in which spinal discs are damaged either because of age related degeneration, playing sports, accidents, or other physical and genetic conditions. The spinal disc is the cushion between the bones or vertebra in the spine that allows for motion and stability. Currently, there is no treatment to regenerate the spinal disc, which often relates to intense pain causing patients to turn to major surgical procedures, that can lead to complications or opioid use, which can lead to addiction. Now, imagine a future where it’s possible to completely heal such injuries and regenerate not only the spinal discs, but also other body tissue and cartilage, restoring them to their original state. The medical implications would be far reaching. This future isn't as far off as one would think, thanks to trailblazers such as HippoFi, Inc. (OTC:ORHB) through its wholly owned subsidiary PUR Biologics. HippoFi’s main goal is to give back to patients the quality of life they had prior to when injuries or the aging process took their toll and eliminate the risks of surgery and dependency on painkillers. PUR’s complete line of biologic products currently includes advanced allografts and demineralized extracellular matrices (d-ECM), innovative synthetic bone-forming solutions, and cellular-derived tissues. In addition to this, the company has several patented and next-generation regenerative stem cell and growth factor driven therapeutics for treating osteoarthritis and cartilage regeneration. PUR’s product and technology portfolio are applicable to multiple large markets which conservatively could be worth about $48 billion providing the opportunity for continued growth, and increased shareholder value. Investors should be most excited for the company’s recent addition to the executive team. There is no one better placed to help HippoFi capitalize on the huge opportunity in regenerative therapeutics than the world’s foremost authority and pioneer of regenerative medicine, Gail Naughton, MBA, Ph.D. Despite their massive potential, very few cell-based products have been approved by regulatory authorities. This is understandable considering these are complex products which are difficult to manufacture. Dr. Naughton has an extensive track-record in this space, with more cell-based products approved by the FDA than nearly anyone else in the world, making her an extremely valuable addition to the team. A pioneer in cell-based therapeutics Dr. Naughton will be HippoFi’s "Head of Regenerative Therapeutics and Commercialization" and has been a driving force in regenerative medicine for over 35 years with a proven track record in monetizing significant cell-based therapeutics and bioengineered tissue technologies in addition to holding more than 140 patents. The first company that Dr. Naughton started and went public with was Advanced Tissue Sciences, which then was acquired by Organogenesis (NASDAQ:ORGO). Advanced Tissue Sciences was started in 1988 and received three of the world’s first regulatory approvals for cell-based products, including approval for Transcyte, a “skin substitute” originally termed Dermagraft, a product placed on diabetic ulcers and used for a soft tissue filler and as a cover to help the tissue heal. The company worked closely with healthcare giant Smith & Nephew (NYSE:SNN), a leader in advanced wound care and orthopedics which very early on recognized the potential of these cell-based products. The joint venture, focused on wound care and orthopedics, not only reaffirmed the potential for these novel cell-based products but also highlighted why Dr. Naughton was indeed the foremost authority on regenerative therapies. At the same time, Advanced Tissue Sciences licensed its first skincare product to a company called SkinMedica which was eventually acquired by Allergan. Though AbbVie (NYSE:ABBV) bought out Allergan, that skincare product is still being sold. Dr. Naughton went on to start a second company called Histogen which went public as well. The company focuses on growing cells under embryonic conditions of very low oxygen and low gravity in order to revert the cells back to a stem-cell like condition. It then uses the byproducts of those cells in a very controlled manufacturing process to produce growth factors and extra-cellular matrix for a variety of reasons, including the regeneration of spinal discs which has demonstrated success in animal trials and the regeneration of the surface cartilage in joints which has gone to clinical trials. Dr. Naughton understands the pathways and potential pitfalls of bringing cellular and cellular derived technologies through the manufacturing process, animal trials, and clinical trials as well as working closely with the FDA which will be instrumental for HippoFi going forward. Furthermore, Dr. Naughton oversaw the design and development of the world’s first up-scaled manufacturing facility for tissue engineered products reaffirming her position as the world’s leading mind in manufactured cell-based products. Although currently focused on spine, the company has the ability to develop other orthopedic and bone care products as well as improve current products. Expediting the development of regenerative therapies HippoFi, Inc. (OTC:ORHB) has already achieved significant success in the regenerative therapies space, succeeding where others have failed. With the new commitment to work with Dr. Naughton, their combined efforts and revolutionary vision should be able to expedite the development of fully functioning biologics solutions in orthopedics that not only regenerate but restore function. One of Dr. Naughton and Hippofi’s first moves will be to continue the work she has been doing which has already shown success in animal studies. The exceptional results from these studies have shown that these novel biologic solutions could regenerate the spinal discs to the way they were before they had degenerated or were damaged, which ties in well with HippoFi’s current product portfolio and innovation focus. With such encouraging results, this means that the treatments would essentially be able to ‘turn the clock backwards’ and restore a patient’s tissues, functionality, and pain levels to the point they were before aging, disease, or injury. Dr. Naughton recently had success getting into clinical trials for human cartilage regeneration, another key area of focus for HippoFi. This is different than repairing because when tissue repairs it usually leaves a scar. HippoFi’s goal is to be able to have the normal tissue / cartilage / disc to regenerate back to where it was originally, without scarring. Right now, HippoFi is focused on the spine, mostly targeting bone growth products to help heal following spinal fusion procedures. And while that has been a great advancement for the patients, the company is concentrating on spine first because that’s where it has extensive experience and worldwide sales channels to drive today’s revenues. While Dr. Naughton also has significant experience in spine; their shared vision and experience will expand their target to other areas as they make more successes. Takeaway Although cell-based and cell-derived products and regenerative therapies have been around since the mid-80s, there are only a handful of products that have been approved by the FDA which has recently opened up new pathways to approval, seeing the importance of these technologies related to the future of patient care. With the addition or Dr. Naughton, and the company’s issued patent portfolio, HippoFi, Inc. (OTC:ORHB) is well positioned to change this and lead the future of regenerative medicine. With her extensive background in regenerative medicine and regulatory pathways combined with HippoFi’s business, sales, and clinical expertise they have clearly created a vision and strategy to expedite these innovative products to the patients that need them most - starting with spinal discs and osteoarthritis, and then moving forward with the regeneration of cartilage in knees and other joints.. For now, it seems that is the perfect time for investors to keep a watchful eye on HippoFi, and the addition of Dr. Naughton will be a major catalyst in helping the company meet their goals and address the significant and unmet needs in the $200 billion osteoarthritis, pain, and cartilage & spinal disc regeneration markets. Although the company currently has a market cap of just about $25 million, it may not remain at that valuation for too long once it starts gaining mainstream attention. Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, or assumptions of future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. Capital Gains Report (CGR), owned by RazorPitch Inc., is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR has been retained by HippoFi Inc to produce and distribute this content. As part of that content, readers, subscribers, and webs are expected to read the full disclaimers and financial disclosure statement that can be found on our website capitalgainsreport.com All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any persons use of or access to this content. Contact Details CapitalGainsReport.com Mark McKelvie +1 585-301-7700 markrmckelvie@gmail.com

December 08, 2023 07:35 AM Eastern Standard Time

Article thumbnail News Release

Intelligent Health 2023 Global Summit Features Keynote by AI Luminary Tom Lawry

1BusinessWorld

The Intelligent Health 2023 Global Summit, a cornerstone event for healthcare innovation, is proud to announce a must-attend session, “The Intelligent Health Revolution is Upon Us. Are You Ready?” featuring Tom Lawry, the Managing Director of Second Century Tech. Scheduled for December 11, 2023, from 1:00 pm to 1:30 pm, this virtual event promises to be a beacon of knowledge for healthcare professionals, technologists, and innovators worldwide. https://1businessworld.com/2023-intelligent-health-summit/ Tom Lawry, a globally recognized AI keynote speaker and a transformative advisor in health and medical fields, will lead the session. Lawry's extensive career includes notable roles such as National Director for AI for Health and Life Sciences and Director of Worldwide Health at Microsoft. He is also the acclaimed author of “Hacking Healthcare – How AI and the Intelligent Health Revolution Will Reboot an Ailing System.” His thought leadership has been featured in prestigious publications like Forbes, CEO Magazine, and Harvard Business Review. The session will delve into the burgeoning Intelligent Health Revolution, with a focus on the integration and profound impact of AI in healthcare. Lawry will share his invaluable insights on how AI is reshaping healthcare delivery, enhancing patient engagement, and boosting system efficiency. He will also discuss adaptive strategies for healthcare organizations in this rapidly evolving technological landscape. Tom Lawry’s unique blend of expertise and experience positions him as a visionary voice at the intersection of technology and healthcare. Attendees will benefit from his perspectives, shaped by his roles as a health system executive and board member. This session is a rare opportunity for attendees to engage with one of the most influential voices in healthcare technology, as recognized by a Harris Poll of attendees at the 2023 JP Morgan Healthcare Conference. The Intelligent Health 2023 Global Summit, produced by the Intelligent Health Association and powered by 1BusinessWorld, is dedicated to exploring the future of healthcare. This session with Tom Lawry is a testament to the summit’s commitment to bringing the forefront of healthcare innovation to a global audience. We invite healthcare professionals, technologists, and anyone interested in the future of health and AI to join this enlightening session. Register now to secure your virtual seat and be part of the Intelligent Health Revolution. https://1businessworld.com/2023-intelligent-health-summit/ All news and content distribution in partnership with News Direct. About the Intelligent Health Association: The Intelligent Health Association (IHA) is a global consortium of healthcare and technology leaders committed to advancing digital healthcare. Our goal is to disseminate unbiased information on innovative technologies that enhance patient care and improve clinical and business processes. The IHA champions the transformation of healthcare through high-quality educational programs and networking events, facilitating the adoption and implementation of new technologies in health and wellness ecosystems. We are dedicated to reshaping healthcare through innovation and leadership, ensuring a future where technology seamlessly integrates with patient care. Intelligent Health Association About 1BusinessWorld: 1BusinessWorld is a global business ecosystem, network and marketplace that provides entrepreneurs, business owners and professionals with the information, tools, resources and connectivity needed to succeed throughout their company’s growth journey, toward a better business world. Our vision is based on the reality that we live, work and do business in one global interconnected business environment, and hence our motto: “One World, One Business World”. Our mission is to encourage and support global communication and collaboration among entrepreneurs, professionals, and businesses. 1BusinessWorld Contact Details Media Enquiries +1 212-220-6677 info@1businessworld.com Company Website https://1businessworld.com

December 05, 2023 10:54 AM Eastern Standard Time

Image
1 ... 910111213 ... 88